Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,434.00    44.00 (1.84%)
Bid:
2,434.00
Ask:
2,436.00
Spread: 2.00 (0.082%)
Market Cap: £7.81b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

24 Jun 2021 07:00

RNS Number : 8988C
Bunzl PLC
24 June 2021
 

24 June 2021

 

BUNZL PRE CLOSE STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the six months ending 30 June 2021.

 

Bunzl's diversified and resilient business model has delivered good overall growth against continuing pandemic-related challenges. Group revenue in the first half is expected to increase by approximately 1% at actual exchange rates and to increase by 6% to 7% at constant exchange rates, with the impact of acquisitions being slightly higher than underlying revenue growth and a small impact from fewer trading days. At constant exchange rates, underlying revenue growth is expected to reflect a strong recovery in the base business, including the foodservice and retail sectors, largely offset by the anticipated decline in larger Covid-19 related orders. Underlying revenue over the first half is expected to be approximately 6% higher than the comparable 2019 period. Group adjusted operating margin for the first half is expected to be nearly 1% higher than that achieved in the first half of 2019 supported by smaller Covid-19 related orders.

 

The Group's revenue guidance for the year remains unchanged from that published in our first quarter trading statement. At constant exchange rates, underlying revenue is expected to be moderately higher in 2021 compared to 2019, demonstrating the resilience of the Bunzl business model. The Group is increasing its adjusted operating margin expectations for the year to be slightly ahead of historical levels.

 

The Group also announces today that at the end of May we completed the acquisition of two businesses. Comax is a distributor to the leisure, janitorial, care home and foodservice sectors in the UK, supplying an array of cleaning and hygiene products, as well as catering and kitchen supplies. Comax generated revenue of £14 million in 2020. The Group also completed the acquisition of Harvey Distributors, a cleaning & hygiene distributor in Australia with customers in the healthcare, education, foodservice and facilities management sectors. Harvey Distributors generated revenue in 2020 of AUD 7 million (c.£4 million).

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Growth through acquisitions is an important part of the ongoing strategy for Bunzl and I am pleased to welcome both Comax and Harvey Distributors to the Bunzl family. Both businesses strengthen the Group's cleaning & hygiene operations, an area we expect will be supported by enhanced hygiene trends. Inclusive of these acquisitions the Group has now acquired six businesses since the start of the year with a total committed spend of £114 million. The pipeline for acquisitions remains active, with discussions ongoing."

 

Bunzl plc will be holding a Capital Markets Day in London on 11th October 2021.

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Richard Howes, Finance Director

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDLBXDDGBX
Date   Source Headline
29th Aug 201712:15 pmRNSDividend Declaration
29th Aug 20177:00 amRNSHalf-year Report
29th Aug 20177:00 amRNSAcquisition
15th Aug 201710:13 amRNSAdditional Listing
9th Aug 20172:56 pmRNSHolding(s) in Company
7th Aug 201712:09 pmRNSHolding(s) in Company
2nd Aug 20172:56 pmRNSHolding(s) in Company
1st Aug 201710:34 amRNSTotal Voting Rights
20th Jul 20177:00 amRNSAcquisition
14th Jul 20171:12 pmRNSDirector/PDMR Shareholding
5th Jul 20173:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20172:01 pmRNSTotal Voting Rights
3rd Jul 20179:50 amRNSHolding(s) in Company
3rd Jul 20179:00 amRNSDirector Declaration
28th Jun 20177:00 amRNSTrading Statement
6th Jun 20171:13 pmRNSDirector/PDMR Shareholding
2nd Jun 20173:51 pmRNSHolding(s) in Company
1st Jun 201710:26 amRNSTotal Voting Rights
24th May 20177:00 amRNSAcquisition
3rd May 20174:47 pmRNSDirector/PDMR Shareholding
3rd May 20174:42 pmRNSBlock listing Interim Review
2nd May 20174:21 pmRNSDirector/PDMR Shareholding
2nd May 20174:19 pmRNSDirector/PDMR Shareholding
2nd May 20173:35 pmRNSTotal Voting Rights
27th Apr 20175:38 pmRNSDirector/PDMR Shareholding
26th Apr 20179:54 amRNSAdditional Listing
19th Apr 20172:20 pmRNSResult of AGM
19th Apr 20177:00 amRNSTrading Statement
13th Apr 20171:56 pmRNSDirector/PDMR Shareholding
13th Apr 201710:21 amRNSAdditional Listing
11th Apr 20175:12 pmRNSDirector/PDMR Shareholding
7th Apr 20175:12 pmRNSDirector/PDMR Shareholding
6th Apr 20174:16 pmRNSDirector/PDMR Shareholding
4th Apr 20174:34 pmRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAcquisition
3rd Apr 20179:43 amRNSTotal Voting Rights
28th Mar 201712:37 pmRNSDirector/PDMR Shareholding
28th Mar 20179:42 amRNSDirectorate Change
16th Mar 20174:28 pmRNSAnnual Financial Report
14th Mar 201711:01 amRNSDirector Declaration
6th Mar 20175:54 pmRNSDirector/PDMR Shareholding
6th Mar 20173:49 pmRNSHolding(s) in Company
3rd Mar 20173:38 pmRNSDirector/PDMR Shareholding
2nd Mar 20174:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20172:10 pmRNSDirector/PDMR Shareholding
1st Mar 20174:27 pmRNSTotal Voting Rights
1st Mar 20177:00 amRNSAcquisition
27th Feb 20171:30 pmRNSDividend Declaration
27th Feb 20177:00 amRNSDirectorate Change
27th Feb 20177:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.